DE3855575D1 - Wasserlösliche Camptothecin-Analoge - Google Patents
Wasserlösliche Camptothecin-AnalogeInfo
- Publication number
- DE3855575D1 DE3855575D1 DE3855575T DE3855575T DE3855575D1 DE 3855575 D1 DE3855575 D1 DE 3855575D1 DE 3855575 T DE3855575 T DE 3855575T DE 3855575 T DE3855575 T DE 3855575T DE 3855575 D1 DE3855575 D1 DE 3855575D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- hydrogen
- water soluble
- ch2nh2
- formyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12714887A | 1987-12-01 | 1987-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3855575D1 true DE3855575D1 (de) | 1996-10-31 |
DE3855575T2 DE3855575T2 (de) | 1997-03-20 |
Family
ID=22428545
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1997175017 Active DE19775017I2 (de) | 1987-12-01 | 1988-11-30 | Wasserloesliche Camptothecin-Analoge |
DE3855575T Expired - Lifetime DE3855575T2 (de) | 1987-12-01 | 1988-11-30 | Wasserlösliche Camptothecin-Analoge |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1997175017 Active DE19775017I2 (de) | 1987-12-01 | 1988-11-30 | Wasserloesliche Camptothecin-Analoge |
Country Status (25)
Country | Link |
---|---|
US (1) | US5004758A (de) |
EP (1) | EP0321122B1 (de) |
JP (1) | JPH0633268B2 (de) |
KR (1) | KR930009357B1 (de) |
CN (3) | CN1027265C (de) |
AT (1) | ATE143368T1 (de) |
AU (1) | AU612735B2 (de) |
CA (1) | CA1308102C (de) |
CY (1) | CY2017A (de) |
DE (2) | DE19775017I2 (de) |
DK (1) | DK173034B1 (de) |
ES (1) | ES2094721T3 (de) |
FI (1) | FI89923C (de) |
GR (1) | GR3021990T3 (de) |
HK (1) | HK81097A (de) |
IE (1) | IE74873B1 (de) |
IL (1) | IL88517A (de) |
LU (2) | LU90026I2 (de) |
MX (1) | MX9203744A (de) |
NL (1) | NL970017I2 (de) |
NO (2) | NO170487C (de) |
NZ (1) | NZ227124A (de) |
PT (1) | PT89111B (de) |
SG (1) | SG66254A1 (de) |
ZA (1) | ZA888938B (de) |
Families Citing this family (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5122526A (en) * | 1987-03-31 | 1992-06-16 | Research Triangle Institute | Camptothecin and analogs thereof and pharmaceutical compositions and method using them |
US5053512A (en) * | 1987-04-14 | 1991-10-01 | Research Triangle Institute | Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives |
US5106742A (en) * | 1987-03-31 | 1992-04-21 | Wall Monroe E | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5227380A (en) * | 1987-03-31 | 1993-07-13 | Research Triangle Institute | Pharmaceutical compositions and methods employing camptothecins |
US5364858A (en) * | 1987-03-31 | 1994-11-15 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
US5122606A (en) * | 1987-04-14 | 1992-06-16 | Research Triangle Institute | 10,11-methylenedioxy camptothecins |
US5049668A (en) * | 1989-09-15 | 1991-09-17 | Research Triangle Institute | 10,11-methylenedioxy-20(RS)-camptothecin analogs |
US5180722A (en) * | 1987-04-14 | 1993-01-19 | Research Triangle Institute | 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs |
US5340817A (en) * | 1987-04-14 | 1994-08-23 | Research Triangle Institute | Method of treating tumors with anti-tumor effective camptothecin compounds |
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US5552154A (en) * | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
JP2684104B2 (ja) * | 1990-02-09 | 1997-12-03 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
ES2137932T3 (es) * | 1990-09-28 | 2000-01-01 | Smithkline Beecham Corp | Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina. |
US5883255A (en) * | 1990-10-31 | 1999-03-16 | Smithkline Beecham Corporation | Substituted indolizino 1,2-b!quinolinones |
DK0572549T3 (da) * | 1991-02-21 | 2003-01-06 | Smithkline Beecham Corp | Behandling af ikke-småcellet lungecarcinom |
EP1707568B1 (de) * | 1991-02-21 | 2010-08-04 | GlaxoSmithKline LLC | Pharmazeutische Zusammensetzung zur Verwendung in der Behandlung von Eierstockkrebs |
JPH06505487A (ja) * | 1991-02-21 | 1994-06-23 | スミスクライン・ビーチャム・コーポレイション | 食道癌の治療用医薬組成物 |
US5559235A (en) * | 1991-10-29 | 1996-09-24 | Glaxo Wellcome Inc. | Water soluble camptothecin derivatives |
ES2086643T3 (es) * | 1991-10-29 | 1996-07-01 | Glaxo Wellcome Inc | Derivados de camptotecina solubles en agua. |
CA2123321C (en) | 1991-11-15 | 2003-09-30 | Randall Keith Johnson | Combination chemotherapy |
WO1993011770A1 (en) * | 1991-12-10 | 1993-06-24 | Smithkline Beecham Corporation | Treatment of colorectal cancer |
US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
US5446047A (en) * | 1992-07-23 | 1995-08-29 | Sloan-Kettering Institute For Cancer Research | Camptothecin analogues |
US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
EP0655919A4 (de) * | 1992-08-21 | 1995-10-18 | Dana Farber Cancer Inst Inc | Behandlung von virusinfektionen beim menschen. |
US5342947A (en) * | 1992-10-09 | 1994-08-30 | Glaxo Inc. | Preparation of water soluble camptothecin derivatives |
AP9300587A0 (en) * | 1992-11-12 | 1995-05-05 | Glaxo Inc | Water soluble camptothecin derivatives. |
US5674872A (en) * | 1993-08-20 | 1997-10-07 | Smithkline Beecham Corporation | Treatment of ovarian cancer |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
CA2174350A1 (en) * | 1993-10-20 | 1995-04-27 | Richard B. Greenwald | 2'- and/or 7- substituted taxoids |
US5436243A (en) * | 1993-11-17 | 1995-07-25 | Research Triangle Institute Duke University | Aminoanthraquinone derivatives to combat multidrug resistance |
US5447936A (en) * | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
US5468754A (en) * | 1994-04-19 | 1995-11-21 | Bionumerik Pharmaceuticals, Inc. | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
US5604233A (en) * | 1994-04-28 | 1997-02-18 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof |
US5597829A (en) * | 1994-05-09 | 1997-01-28 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of camptothecin and methods for uses thereof |
CA2188297C (en) * | 1994-04-28 | 2006-12-19 | Frederick Herman Hausheer | Lactone stable formulation of camptothecin or 7-ethyl camptothecin |
US5491237A (en) * | 1994-05-03 | 1996-02-13 | Glaxo Wellcome Inc. | Intermediates in pharmaceutical camptothecin preparation |
US5834442A (en) * | 1994-07-07 | 1998-11-10 | Barbara Ann Karmanos Cancer Institute | Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
US5646159A (en) * | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
US6504029B1 (en) * | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
GB9510716D0 (en) * | 1995-05-26 | 1995-07-19 | Pharmacia Spa | Substituted camptothecin derivatives and process for their preparation |
US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
US5670500A (en) * | 1995-05-31 | 1997-09-23 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
CA2223484A1 (en) * | 1995-06-07 | 1996-12-19 | Thomas Jefferson University | Anti-fungal agents and methods of identifying and using the same |
AU7732996A (en) * | 1995-11-22 | 1997-06-11 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
US6395541B1 (en) | 1996-05-23 | 2002-05-28 | The Rockefeller University | Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I |
CA2262745C (en) * | 1996-08-19 | 2006-04-04 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
US6013505A (en) | 1996-10-08 | 2000-01-11 | Smithkline Beecham Corporation | Topoisomerase I |
US5962303A (en) | 1996-10-15 | 1999-10-05 | Smithkline Beecham Corporation | Topoisomerase III |
US6025156A (en) * | 1996-10-15 | 2000-02-15 | Smithkline Beecham Corporation | Topoisomerase III |
US6559309B2 (en) | 1996-11-01 | 2003-05-06 | Osi Pharmaceuticals, Inc. | Preparation of a camptothecin derivative by intramolecular cyclisation |
WO1998035940A1 (en) * | 1997-02-14 | 1998-08-20 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
US6207673B1 (en) * | 1997-03-12 | 2001-03-27 | The University Of North Carolina At Chapel Hill | Covalent conjugates of topoisomerase I and topoisomerase II inhibitors |
ID23424A (id) | 1997-05-14 | 2000-04-20 | Bayer Ag | Glikokonjugat dari 20(s)-kamptotesin |
US6046209A (en) * | 1997-05-27 | 2000-04-04 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
CA2243363C (en) * | 1997-07-17 | 2002-01-29 | Kuraray Co., Ltd. | Process for producing chromans |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
US6214821B1 (en) | 1998-03-05 | 2001-04-10 | Washington State University Research Foundation | Methods and composition for the inhibition of cancer cells |
CZ295775B6 (cs) * | 1998-08-05 | 2005-11-16 | Aventis Pharma S. A. | Perorálně podatelné činidlo pro omezení nebo potlačení sekundárních gastrointestinálních účinků způsobených podáním derivátů kamptothecinu |
CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
FR2801309B1 (fr) * | 1999-11-18 | 2002-01-04 | Adir | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6288072B1 (en) * | 1999-12-29 | 2001-09-11 | Monroe E. Wall | Camptothecin β-alanine esters with topoisomerase I inhibition |
MXPA02008355A (es) | 2000-02-28 | 2002-12-13 | Aventis Pharma Sa | Composicion que comprende camptotecina y derivado de pirimidina para tratamiento del cancer. |
US6548488B2 (en) | 2000-03-17 | 2003-04-15 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
US6545010B2 (en) | 2000-03-17 | 2003-04-08 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer |
AR027687A1 (es) * | 2000-03-22 | 2003-04-09 | Yakult Honsha Kk | Procedimiento para preparar camptotecina |
US6486320B2 (en) | 2000-09-15 | 2002-11-26 | Aventis Pharma S.A. | Preparation of camptothecin and of its derivatives |
EE200300184A (et) | 2000-10-27 | 2003-08-15 | Aventis Pharma S.A. | Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks |
WO2002040653A2 (en) * | 2000-11-14 | 2002-05-23 | Emerald Biostructures, Inc. | Chrystal compositions comprising topoisomerase i |
IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
EA009082B1 (ru) * | 2002-03-26 | 2007-10-26 | СиСиАй КОРПОРЕЙШН | Агент для улучшения химиотерапии рака |
ITRM20020306A1 (it) * | 2002-05-31 | 2003-12-01 | Sigma Tau Ind Farmaceuti | Esteri in posizione 20 di camptotecine. |
US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
US20040062748A1 (en) * | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
US7563810B2 (en) * | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US8034831B2 (en) * | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
WO2004055020A1 (en) * | 2002-12-16 | 2004-07-01 | Council Of Scientific And Industrial Research | Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
FR2852606A1 (fr) * | 2003-03-18 | 2004-09-24 | Inst Nat Sante Rech Med | Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie |
EP1608660B1 (de) * | 2003-03-31 | 2007-10-10 | Council of Scientific and Industrial Research | Verfahren zur herstellung von topotecan aus 10-hydroxy-4-(s) camtothecin |
CN100406460C (zh) * | 2003-11-10 | 2008-07-30 | 中国科学院上海药物研究所 | 喜树碱的新衍生物、制备方法和用途 |
AR046579A1 (es) * | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica |
AU2005222384A1 (en) | 2004-03-05 | 2005-09-22 | Vegenics Limited | Growth factor binding constructs materials and methods |
MXPA06012145A (es) | 2004-04-27 | 2007-01-31 | Wellstat Biologics Corp | Tratamiento del cancer utilizando virus y camptotecinas. |
US20050267141A1 (en) | 2004-05-28 | 2005-12-01 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives |
US20050272757A1 (en) * | 2004-06-04 | 2005-12-08 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
US7122700B2 (en) * | 2004-07-30 | 2006-10-17 | Xerox Corporation | Arylamine processes |
US20090104254A1 (en) | 2004-12-22 | 2009-04-23 | Rutgers, The State University Of New Jersey | Controlled Release Hydrogels |
US20080161251A1 (en) | 2005-01-21 | 2008-07-03 | Astex Therapeutics Limited | Pharmaceutical Compounds |
JP5106098B2 (ja) * | 2005-02-28 | 2012-12-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド化合物の抗癌剤との新規併用 |
CA2612949C (en) * | 2005-07-14 | 2015-04-28 | Wellstat Biologics Corporation | Cancer treatment using viruses, fluoropyrimidines and camptothecins |
WO2007042799A1 (en) * | 2005-10-10 | 2007-04-19 | Cipla Limited | Novel crystalline forms |
US7786134B2 (en) | 2005-12-16 | 2010-08-31 | Sonus Pharmaceuticals, Inc. | Lipophilic anticancer drug compounds, compositions and related methods |
US7547785B2 (en) | 2005-12-26 | 2009-06-16 | Dr. Reddy's Laboratories Limited | Process for preparing topotecan |
WO2007085370A1 (en) * | 2006-01-25 | 2007-08-02 | Heidelberg Pharma Ag | 9-(dimethylamino)-methyl-10-hydroxy-camptothecin lipidester derivatives |
CN101033230B (zh) * | 2006-03-10 | 2010-12-08 | 中国科学院上海药物研究所 | 一类喜树碱衍生物及其应用 |
US8410045B2 (en) | 2006-03-30 | 2013-04-02 | Drais Pharmaceuticals, Inc. | Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
WO2007127839A2 (en) * | 2006-04-26 | 2007-11-08 | The Regents Of The University Of California | Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
WO2008021549A2 (en) * | 2006-08-18 | 2008-02-21 | Sidney Kimmel Cancer Center | Methods and compositions for topoisomerase i modulated tumor suppression |
WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
EP2073807A1 (de) | 2006-10-12 | 2009-07-01 | Astex Therapeutics Limited | Pharmazeutische kombinationen |
US7977483B2 (en) * | 2007-04-11 | 2011-07-12 | Scinopharm Taiwan, Ltd. | Process for making topotecan |
US20080255175A1 (en) * | 2007-04-16 | 2008-10-16 | Lam Marina K | Anti-cancer agents, compositions and methods of treating cancers |
US8013158B2 (en) * | 2007-04-19 | 2011-09-06 | Scinopharm Taiwan Ltd. | Crystalline forms of topotecan hydrochloride and processes for making the same |
US8026249B2 (en) * | 2007-09-14 | 2011-09-27 | Deutena Pharmaceuticals, Inc. | Deuterium-enriched topotecan |
ITMI20072268A1 (it) | 2007-12-04 | 2009-06-05 | Antibioticos Spa | Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione |
ES2425621T3 (es) * | 2008-05-29 | 2013-10-16 | Microbiopharm Japan Co., Ltd. | Métodos para producir derivados de camptotecina |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
CN102753563A (zh) * | 2008-12-23 | 2012-10-24 | 吉利德制药有限责任公司 | 核苷类似物 |
AR074977A1 (es) | 2008-12-23 | 2011-03-02 | Pharmasset Inc | Sintesis de nucleosidos de purina |
PT2376088T (pt) * | 2008-12-23 | 2017-05-02 | Gilead Pharmasset Llc | Fosforamidatos de nucleósidos de 2-amino-purina 6-osubstituída |
EP2547359B1 (de) | 2010-03-15 | 2016-03-09 | The Board of Trustees of the University of Illionis | Hemmer von interaktionen, die beta-integrin-g protein-alpha-untereinheit binden |
CN102858790A (zh) | 2010-03-31 | 2013-01-02 | 吉利德制药有限责任公司 | 核苷氨基磷酸酯 |
US20140086975A1 (en) | 2010-10-15 | 2014-03-27 | Rutgers, The State University Of New Jersey | Hydrogel formulation for dermal and ocular delivery |
RU2447076C1 (ru) * | 2010-12-09 | 2012-04-10 | Закрытое Акционерное Общество "Фарм-Синтез" | Способ получения топотекана |
EP2654754B1 (de) | 2010-12-17 | 2016-12-21 | Novartis AG | Kombination zur behandlung von osteosarcoma, rhabdomyosarcoma und neuroblastoma |
WO2012083197A1 (en) | 2010-12-17 | 2012-06-21 | Nektar Therapeutics | Water-soluble polymer conjugates of topotecan |
WO2012087943A2 (en) | 2010-12-20 | 2012-06-28 | The Regents Of The University Of Michigan | Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
EP2672969A4 (de) | 2011-02-01 | 2014-07-16 | Glaxosmithkline Intellectual Property Ltd | Kombination |
ES2673957T5 (es) | 2011-10-03 | 2021-12-15 | Croda Int Plc | Nanopartículas, procedimiento para la preparación y utilización de las mismas como portadoras de moléculas anfipáticas o hidrofóbicas en el campo de la medicina, incluyendo el tratamiento del cáncer, y compuestos de tipo alimentario |
PL235836B1 (pl) * | 2012-10-25 | 2020-11-02 | Inst Chemii Organicznej Polskiej Akademii Nauk | Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie |
CN103113381B (zh) * | 2013-02-26 | 2014-12-10 | 大连理工大学 | 系列水溶性羟基喜树碱环烷胺醇衍生物及其制法与用途 |
WO2014163558A1 (en) | 2013-04-01 | 2014-10-09 | Moreinx Ab | Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds |
EP3250609A4 (de) | 2015-01-26 | 2018-07-11 | The University of Chicago | Il13ra-alpha-2-bindende wirkstoffe und verwendung davon bei der krebsbehandlung |
CN107835820B (zh) | 2015-01-26 | 2021-10-15 | 芝加哥大学 | 识别癌症特异性IL13Rα2的CAR T细胞 |
US10517961B2 (en) | 2015-09-25 | 2019-12-31 | ZY Therapeutics, Inc. | Drug formulation based on particulates comprising polysaccharide-vitamin conjugate |
IL261721B (en) | 2016-03-15 | 2022-07-01 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for use in the treatment of solid tumors |
PL3622953T3 (pl) * | 2016-05-17 | 2021-08-16 | Scandion Oncology A/S | Leczenie skojarzone nowotworu |
US20200254037A1 (en) | 2017-08-07 | 2020-08-13 | Amgen Inc. | Treatment of triple negative breast cancer or colorectal cancer with liver metastases with an anti pd-l1 antibody and an oncolytic virus |
EP3669890A1 (de) | 2018-12-18 | 2020-06-24 | Croda International PLC | Filamentöse nanopartikel mit impfstoffadjuvanswirkung |
MX2021011330A (es) | 2019-03-20 | 2021-12-10 | Univ California | Anticuerpos de claudina-6 y conjugados de fármacos. |
WO2020210376A1 (en) | 2019-04-09 | 2020-10-15 | The Board Of Trustees Of The University Of Illinois | Drug adsorbed highly porous activated carbon for enhanced drug delivery |
MX2021013271A (es) | 2019-04-30 | 2022-01-06 | Inst De Medicina Molecular Joao Lobo Antunes | Inhibidores de la via rank en combinacion con inhibidores de cdk. |
US20220305081A1 (en) | 2019-06-24 | 2022-09-29 | Amgen Inc. | Inhibitions of sirp-gamma for cancer treatment |
US20220265659A1 (en) | 2019-09-02 | 2022-08-25 | Inserm (Institut National De La Santé Et De Al Recherche Médicale) | Methods and compositions for treating pax6-deficiency related disease |
WO2023220641A2 (en) | 2022-05-11 | 2023-11-16 | Juno Therapeutics, Inc. | Methods and uses related to t cell therapy and production of same |
CN116478174A (zh) * | 2022-07-29 | 2023-07-25 | 杭州爱科瑞思生物医药有限公司 | 喜树碱衍生物及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399282A (en) * | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
US4342776A (en) * | 1979-11-05 | 1982-08-03 | Merck & Co., Inc. | 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase |
JPS58134095A (ja) * | 1982-02-05 | 1983-08-10 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS58154582A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
JPS58154584A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 5位ヒドロキシ置換カンプトテシン誘導体の製造法 |
JPS5951289A (ja) * | 1982-09-17 | 1984-03-24 | Yakult Honsha Co Ltd | 新規な9−置換−カンプトテシン誘導体 |
JPS59227884A (ja) * | 1983-06-09 | 1984-12-21 | Yakult Honsha Co Ltd | 新規な7−ヒドロキシアルキルカンプトテシン誘導体 |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
US4775759A (en) * | 1984-11-27 | 1988-10-04 | The United States Of America As Represented By The Department Of Health And Human Services | Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT) |
US4820816A (en) * | 1985-08-02 | 1989-04-11 | President And Fellows Of Harvard College | 3-trifuoromethylsulfonyloxy-substituted 1-carbacephalosporins as intermediates for antibiotics |
JPH0615546B2 (ja) * | 1986-02-24 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
US4894456A (en) * | 1987-03-31 | 1990-01-16 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
JP3431931B2 (ja) * | 1992-07-16 | 2003-07-28 | 旭電化工業株式会社 | 銅及び銅合金の表面処理方法 |
-
1988
- 1988-11-02 US US07/266,460 patent/US5004758A/en not_active Expired - Lifetime
- 1988-11-28 DK DK198806636A patent/DK173034B1/da not_active IP Right Cessation
- 1988-11-28 IL IL8851788A patent/IL88517A/en not_active IP Right Cessation
- 1988-11-29 PT PT89111A patent/PT89111B/pt not_active IP Right Cessation
- 1988-11-29 NZ NZ227124A patent/NZ227124A/en unknown
- 1988-11-29 ZA ZA888938A patent/ZA888938B/xx unknown
- 1988-11-30 SG SG1996005126A patent/SG66254A1/en unknown
- 1988-11-30 AU AU26394/88A patent/AU612735B2/en not_active Expired
- 1988-11-30 EP EP88311366A patent/EP0321122B1/de not_active Expired - Lifetime
- 1988-11-30 IE IE357688A patent/IE74873B1/en not_active IP Right Cessation
- 1988-11-30 FI FI885569A patent/FI89923C/fi not_active IP Right Cessation
- 1988-11-30 DE DE1997175017 patent/DE19775017I2/de active Active
- 1988-11-30 LU LU90026C patent/LU90026I2/fr unknown
- 1988-11-30 AT AT88311366T patent/ATE143368T1/de active
- 1988-11-30 CA CA000584544A patent/CA1308102C/en not_active Expired - Lifetime
- 1988-11-30 ES ES88311366T patent/ES2094721T3/es not_active Expired - Lifetime
- 1988-11-30 NO NO885352A patent/NO170487C/no not_active IP Right Cessation
- 1988-11-30 DE DE3855575T patent/DE3855575T2/de not_active Expired - Lifetime
- 1988-12-01 JP JP63306769A patent/JPH0633268B2/ja not_active Expired - Lifetime
- 1988-12-01 CN CN88108256A patent/CN1027265C/zh not_active Expired - Lifetime
- 1988-12-01 KR KR1019880015971A patent/KR930009357B1/ko not_active IP Right Cessation
-
1992
- 1992-06-29 MX MX9203744A patent/MX9203744A/es unknown
-
1993
- 1993-02-27 CN CN93102886A patent/CN1035380C/zh not_active Expired - Lifetime
- 1993-06-28 CN CN93107879A patent/CN1037574C/zh not_active Expired - Lifetime
-
1996
- 1996-12-11 GR GR960403426T patent/GR3021990T3/el unknown
-
1997
- 1997-03-27 NL NL970017C patent/NL970017I2/nl unknown
- 1997-04-16 LU LU90053C patent/LU90053I2/fr unknown
- 1997-06-12 HK HK81097A patent/HK81097A/xx not_active IP Right Cessation
-
1998
- 1998-01-15 NO NO1998003C patent/NO1998003I1/no unknown
- 1998-02-20 CY CY201798A patent/CY2017A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3855575T2 (de) | Wasserlösliche Camptothecin-Analoge | |
ATE127801T1 (de) | Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung. | |
MY105158A (en) | Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibutors. | |
ES8207180A1 (es) | Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 . | |
AU6216886A (en) | Substituted 2-cyano-2-phenyl ethyl-amine | |
EP0186023A3 (de) | Gallensäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
MX9806229A (es) | Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas. | |
NZ216334A (en) | Spiro imidazolone derivatives and pharmaceutical composition | |
ATE30724T1 (de) | Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten. | |
EP0341837A3 (de) | Glutamsäurederivate | |
DE3665593D1 (en) | Peptide immunostimulants | |
IT1205114B (it) | 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
ES8707939A1 (es) | Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
V448 | Application of spc |
Free format text: PRODUCT NAME: HYCAMTIN - TOPOTECAN HYDROCHLORYD; REGISTRATION NO/DATE: EU/1/96/027/001, EU/1/96/027/002; 19961112 Spc suppl protection certif: 197 75 017 Filing date: 19970502 |
|
8364 | No opposition during term of opposition | ||
V457 | Spc granted |
Free format text: PRODUCT NAME: HYCAMTIN - TOPOTECAN HYDROCHLORYD; REGISTRATION NO/DATE: EU/1/96/027/001, EU/1/96/027/002; 19961112 Spc suppl protection certif: 197 75 017 Filing date: 19970502 |
|
R071 | Expiry of right |
Free format text: PRODUCT NAME: TOPOTECAN ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ, HYDRAT ODER SOLVAT DAVON; NAT. REGISTRATION NO/DATE: EU/1/96/027/001-002 19961112; FIRST REGISTRATION: CH/LI 53857 19961016 Spc suppl protection certif: 19775017 Filing date: 19970502 Expiry date: 20081201 Extension date: 20111016 Effective date: 20111017 |
|
R071 | Expiry of right |
Free format text: PRODUCT NAME: NELARABINE UND SEINE PHARMAZEUTISCH ANNEHMBAREN SALZE, ETHER, ESTER ODER SALZE SOLCHER ESTER; REGISTRATION NO/DATE: EU/1/07/403/001 20070822 Spc suppl protection certif: 122008000003 Filing date: 20080108 Expiry date: 20080528 Extension date: 20130527 Effective date: 20130528 |